Physician profile
Colin Johnson
NPI 1346773512
$3,148.40
in general payments reported to CMS, 2019-2025
8 companies · $494 in 2025
The $494 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.80 · 2022: $95.52 · 2023: $899 · 2024: $1,644 · 2025: $494.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,791 · Travel and Lodging: $1,246.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,791.02 |
| Travel and Lodging | $1,246.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $1,780.10 | 2023-2024 | Altis |
| Boston Scientific Corporation | $622.40 | 2019-2025 | Solyx Sis System, Advantage System, Upsylon |
| Medtronic, INC. | $198.57 | 2022-2025 | Interstim, Altaviva |
| Valencia Technologies Corporation | $185.27 | 2024-2025 | Ecoin Device Kit |
| Axonics, INC. | $179.36 | 2023-2024 | Bulkamid, Axonics |
| Abbvie INC. | $120.57 | 2025 | |
| Applied Medical Resources Corporation | $47.72 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.41 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colin Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.